The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes

NCT01836523 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1398

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1

Interventions

DRUG: liraglutide
DRUG: placebo
DRUG: liraglutide
DRUG: placebo
DRUG: liraglutide
DRUG: placebo

Sponsor

Novo Nordisk A/S